PRAX
Price
$36.22
Change
-$2.28 (-5.92%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
776.29M
57 days until earnings call
VERU
Price
$0.50
Change
-$0.01 (-1.96%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
73.19M
57 days until earnings call
Ad is loading...

PRAX vs VERU

Header iconPRAX vs VERU Comparison
Open Charts PRAX vs VERUBanner chart's image
Praxis Precision Medicines
Price$36.22
Change-$2.28 (-5.92%)
Volume$6.34K
Capitalization776.29M
Veru
Price$0.50
Change-$0.01 (-1.96%)
Volume$3.3K
Capitalization73.19M
PRAX vs VERU Comparison Chart
Loading...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRAX vs. VERU commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRAX is a Hold and VERU is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (PRAX: $38.50 vs. VERU: $0.51)
Brand notoriety: PRAX and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRAX: 168% vs. VERU: 13%
Market capitalization -- PRAX: $776.29M vs. VERU: $73.19M
PRAX [@Biotechnology] is valued at $776.29M. VERU’s [@Biotechnology] market capitalization is $73.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRAX’s FA Score shows that 0 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • PRAX’s FA Score: 0 green, 5 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, PRAX is a better buy in the long-term than VERU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRAX’s TA Score shows that 5 TA indicator(s) are bullish while VERU’s TA Score has 3 bullish TA indicator(s).

  • PRAX’s TA Score: 5 bullish, 5 bearish.
  • VERU’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both PRAX and VERU are a good buy in the short-term.

Price Growth

PRAX (@Biotechnology) experienced а -0.26% price change this week, while VERU (@Biotechnology) price change was -1.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

PRAX is expected to report earnings on May 07, 2025.

VERU is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($776M) has a higher market cap than VERU($73.2M). VERU YTD gains are higher at: -21.091 vs. PRAX (-49.974). VERU has higher annual earnings (EBITDA): -36.2M vs. PRAX (-163.59M). PRAX has more cash in the bank: 357M vs. VERU (24.9M). PRAX has less debt than VERU: PRAX (1.66M) vs VERU (13.9M). VERU has higher revenues than PRAX: VERU (16.9M) vs PRAX (1.61M).
PRAXVERUPRAX / VERU
Capitalization776M73.2M1,060%
EBITDA-163.59M-36.2M452%
Gain YTD-49.974-21.091237%
P/E RatioN/AN/A-
Revenue1.61M16.9M9%
Total Cash357M24.9M1,434%
Total Debt1.66M13.9M12%
FUNDAMENTALS RATINGS
VERU: Fundamental Ratings
VERU
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRAXVERU
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HAS64.350.84
+1.32%
Hasbro
MGRM2.40N/A
N/A
Monogram Orthopaedics
PPERY11.72-0.06
-0.51%
PT Bank Mandiri Persero TBK
MSGE31.85-0.43
-1.33%
Madison Square Garden Entertainment Corp
DNA7.54-0.27
-3.46%
Ginkgo Bioworks Holdings

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
+1.66%
CDXS - PRAX
38%
Loosely correlated
+3.30%
VERU - PRAX
35%
Loosely correlated
-2.82%
CLRB - PRAX
35%
Loosely correlated
+3.79%
SLNO - PRAX
34%
Loosely correlated
-0.36%
CRNX - PRAX
34%
Loosely correlated
-2.43%
More

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with ALLK. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then ALLK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
-2.82%
ALLK - VERU
49%
Loosely correlated
+2.85%
PXXLF - VERU
37%
Loosely correlated
N/A
PRAX - VERU
35%
Loosely correlated
+1.66%
QLGN - VERU
34%
Loosely correlated
-3.70%
SRRK - VERU
32%
Poorly correlated
-0.36%
More